Ola Mohamad Elfarargy

Assessment of bisphosphonates use as adjuvant therapy in breast cancer / تقييم استخدام عقار البيسفسفونات كعلاج تحفظى فى حالات سرطان الثدى Ola Mohamad Elfarargy ; Supervised Zekri Khalid Zekri , Nadia Iskandar Zakhary , Heba M. Rabie Elzawahry - Cairo : Ola Mohamad Elfarargy , 2011 - 168 P. : charts ; 25cm

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical

Breast cancer is the most common cancer in female worldwide and considered commonest cause of cancer related death in female. Inspite of an increasing incidence, breast cancer mortality has been declining. This is the combined result of better education, widespread screening programs and more efficacious adjuvant treatments



Adjuvant therapy Bisphosphonates Breast cancer